Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04040400 · ClinicalTrials.gov registry record · NA
Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection
A NA study, sponsored by University of Louisville.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04040400 is a NA study that was terminated before completion, run by University of Louisville. The registered enrollment target is 5 participants.
The verdict
NCT04040400, a NA study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary purpose of this study is to establish a maximum tolerated dose (MTD) through a dose-escalation trial using intraoperative radiotherapy (IORT) following neurosurgical resection for large brain metastases, and to determine the progression-free survival rate as in the recurrence rate of treated brain metastasis.
Interventions
- RADIATION intraoperative radiotherapy (IORT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2021-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04040400
The ClinicalTrials.gov registry entry for NCT04040400 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intraoperative radiotherapy (IORT) is the first listed.
NCT04040400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04040400 about?
NCT04040400 is a clinical study titled "Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection". The primary purpose of this study is to establish a maximum tolerated dose (MTD) through a dose-escalation trial using intraoperative radiotherapy (IORT) following neurosurgical resection for large brain metastases, and to determine the progression-free survival rate as in the recurrence rate of tre...
What is the current status of trial NCT04040400?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-10-23. Estimated completion is 2021-11-19.
What interventions are being tested in trial NCT04040400?
The interventions under investigation include: intraoperative radiotherapy (IORT) (RADIATION).
Who is sponsoring clinical trial NCT04040400?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.